Genetic Toxicology and DNA Damage Assessment
Genotoxic substances can induce mutations and chromosomal aberrations. This session reviews testing protocols such as the Ames test and comet assay. Mechanisms of DNA repair and cellular response are explored. High-throughput screening methods enable rapid genotoxicity profiling. Case studies show links between genotoxicants and disease outcomes. Regulatory perspectives on permissible exposure limits are discussed. Protecting genetic integrity is fundamental to public health.
Related Conference of Genetic Toxicology and DNA Damage Assessment
November 13-14, 2025
8th International Conference on Global Toxicology and Risk Assessment
Amsterdam, Netherlands
November 27-28, 2025
7th International Conference on Clinical Pharmacology and Toxicology
Zurich, Switzerland
Genetic Toxicology and DNA Damage Assessment Conference Speakers
Recommended Sessions
- Alternative Testing Methods and 3Rs in Toxicology
- Carcinogenic Risk and Chemical-Induced Cancers
- Chemical Risk Assessment Frameworks
- Climate Change and Toxicological Risk
- Computational Toxicology and AI Applications
- Ecotoxicology and Aquatic System Contamination
- Endocrine Disrupting Chemicals and Public Health
- Environmental Toxicology and Ecosystem Impact
- Food Safety and Chemical Contaminants
- Forensic Toxicology and Chemical Poisoning
- Genetic Toxicology and DNA Damage Assessment
- Global Trends in Toxicology Research and Innovation
- Heavy Metals and Toxic Element Exposure
- Human Biomonitoring and Exposure Science
- Immunotoxicology and Hypersensitivity Reactions
- Industrial and Occupational Toxicology
- Nanotoxicology and Engineered Nanomaterials
- Neurotoxicology and Developmental Exposure
- Pesticide Toxicology and Risk Management
- Pharmaceutical Toxicology and Drug Safety
- Regulatory Toxicology and Global Policy Trends
- Risk Communication in Toxicology
- Toxicity of Consumer Products and Personal Care Items
- Toxicogenomics and Systems Toxicology
- Toxicokinetics and Chemical Fate in the Body
Related Journals
Are you interested in
- Adverse Drug Reactions and Pharmacovigilance - clinical pharmacology 2025 (Switzerland)
- Alternative Testing Methods and 3Rs in Toxicology - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Carcinogenic Risk and Chemical-Induced Cancers - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Cardiovascular Pharmacology - clinical pharmacology 2025 (Switzerland)
- Chemical Risk Assessment Frameworks - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Climate Change and Toxicological Risk - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Clinical Toxicology of Drugs of Abuse - clinical pharmacology 2025 (Switzerland)
- Clinical Trials and Regulatory Affairs - clinical pharmacology 2025 (Switzerland)
- Computational Toxicology and AI Applications - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Drug Interactions and Polypharmacy - clinical pharmacology 2025 (Switzerland)
- Ecotoxicology and Aquatic System Contamination - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Emerging Trends in Clinical Pharmacology - clinical pharmacology 2025 (Switzerland)
- Endocrine Disrupting Chemicals and Public Health - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Environmental and Occupational Toxicology - clinical pharmacology 2025 (Switzerland)
- Environmental Toxicology and Ecosystem Impact - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Food Safety and Chemical Contaminants - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Forensic Toxicology and Chemical Poisoning - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Future Directions in Clinical Pharmacology and Toxicology - clinical pharmacology 2025 (Switzerland)
- Genetic Toxicology and DNA Damage Assessment - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Global Trends in Toxicology Research and Innovation - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Heavy Metals and Toxic Element Exposure - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Human Biomonitoring and Exposure Science - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Immunotoxicology and Hypersensitivity Reactions - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Industrial and Occupational Toxicology - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Innovations in Drug Development and Therapeutics - clinical pharmacology 2025 (Switzerland)
- Nanotoxicology and Engineered Nanomaterials - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Natural Products and Toxicology - clinical pharmacology 2025 (Switzerland)
- Neuropharmacology and Toxicology - clinical pharmacology 2025 (Switzerland)
- Neurotoxicology and Developmental Exposure - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Pediatric and Geriatric Pharmacology - clinical pharmacology 2025 (Switzerland)
- Pesticide Toxicology and Risk Management - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Pharmaceutical Toxicology and Drug Safety - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Pharmacogenomics and Personalized Medicine - clinical pharmacology 2025 (Switzerland)
- Pharmacokinetics and Pharmacodynamics - clinical pharmacology 2025 (Switzerland)
- Regulatory Toxicology and Global Policy Trends - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Risk Communication in Toxicology - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Toxicity of Consumer Products and Personal Care Items - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Toxicogenomics and Systems Toxicology - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Toxicokinetics and Chemical Fate in the Body - GLOBAL TOXICOLOGY 2025 (Netherlands)
- Toxicology and Risk Assessment - clinical pharmacology 2025 (Switzerland)